Oh, So That's Who Signed Off on the FBI Spy Operation Into the...
Chuck Schumer Is About to Be Taken Behind the Barn Over This Tweet
Watch Trump Roast a Reporter Over This Silly Question About the East Room...
Trump Just Called Off Planned Immigration 'Surge' In This City – for Now
Trump Administration Is Preparing Unprecedented Action Against Drug Cartels
Nancy Pelosi Just Made a Serious Threat Against ICE Agents
Some Democrats Are Sour on Mandela Barnes Running for Wisconsin Governor
Vance Bridges Faith and Diplomacy: Visits Church of the Holy Sepulchre Amid Peace...
Famous Berlin Drag Queen Under Investigation for Child Porn
NJ Democrat Councilman Calls ICE an 'Invasive Species,' Says Agency Should Be Eliminated
Anti-ICE Protestor Who Called for Violence a 'Human Rights Award' Winner
Vance Claps Back After Jen Psaki's Comments Regarding His Wife
NYC Gubernatorial Candidates Trade Blows Over Scandals in Heated Exchange
Jack Smith Justifies His Secret Subpoenas, Republicans Aren’t Buying It
Stephen Miller Torches Robert De Niro After Nazi Smear on MSNBC
Tipsheet

Tuberville Demands Answers From HHS Secretary Over Restriction of Antibody Treatments

AP Photo/Butch Dill

Health and Human Services (HHS) Secretary Xavier Becerra recently took control of the distribution of life-saving monoclonal antibody (mAb) treatments for coronavirus. The department now has the authority to regulate the distribution and usage of the treatment in all 50 states and restrict states that are using what the government determines as more than the “fair share.” 

Advertisement

Senator Tommy Tuberville (R-AL) argues that the rule singles out Republican-led states, and pushed for an explanation on the decision in a letter to Becerra.

“HHS will now mandate providers appeal to their state health departments for mAb orders. State health departments must then look to HHS to tell them exactly how many doses they are permitted to receive that particular week, dependent on a formula that HHS has yet to explain in specific detail. In the days since this change was reported, my office has been inundated with pleas for help from providers whose mAb orders were not fulfilled. This announced change in policy is already affecting lives – patients are being turned away who otherwise could be treated with mAb drugs. It is imperative that HHS explain why these changes come at such a critical time and why states that most need these treatments the most are being targeted,” Tuberville wrote. “It is my understanding that seven states (Alabama, Florida, Texas, Mississippi, Tennessee, Georgia, and Louisiana – notably, majority-Republican states) were told that they would likely have their supply of mAb drugs reduced by the new protocols. While I certainly understand that these states may have lower vaccination and higher hospitalization rates than others, it stands to reason that they would benefit more from a steady and direct supply of mAb treatments to keep hospitalization rates down.”

Advertisement

 He went on to ask about specific metrics that led to the department’s decision, which the rule does not specify.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement